Skip to content

DR. PH. DE VUSSER

Active
Private limited companyfounded 1998active for 28 yearsHoefstadstraat 93, 3600 Genk, BelgiumKBO/BCE: BE 0462.922.008
Summary

DR. PH. DE VUSSER has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €702,124, of which €966,224 non-recurring income. Equity has been stable since 2018 (±0.7% per year). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-03-1998 Normal situation
Activity
“De uitoefening van de geneeskunde met specialisatie,incasu cardiologie,door de arts-aandeelhouder,met inachtneming van de regels…” (deed in Dutch)From the articles, 10 activitiesNo NACE code in the KBO yet
Establishment unit
2.301.972.326 3600 Genk, since 02-04-1998
Financial year end
31 December
Peppol
Reachable since 09-01-2026

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€1.1m
▲ 635%
Turnover
≈ €2.0m
estimated
Profit
€702,124
▲ 918%
Equity
€1.3m
▲ 114%
Total assets
€1.5m
▲ 127%
Score breakdownlowers riskSize: total assets €1.5mEquity €1.3m (90.8% of total assets)No main activity registeredFounded in 1998Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 80% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 100=
equity 90.8% of total assets
Liquidity 58-3
short-term debt 9.1% · cash 6.1%
Profitability 100+18
return on assets 48.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.2 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €120,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 9.37 (3.5 in 2024), above the usual 1.5. Short-term debt is 9.1% and cash 6.1% of total assets. 9.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 54% on liquidity, 90% on profitability and 93% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Size: total assets €1.5m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €1.3m (90.8% of total assets)
NBB · annual accounts
lowers risk · No main activity registered
KBO
lowers risk · Founded in 1998
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €1.3m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
28 days late
2023
27 days late
2022
21 days late
2021
24 days late
2020
26 days late
2019
90 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 7 accounts on average 31 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Equity rose in 2025from €617,036 to €1.3m ▲ 114% View

Recent changes

  1. · Gazette deed Reappointment: DE VUSSER Philip (director)Resignation: DE VUSSER Philip (manager)
  2. · Gazette deed Incorporation
All 19 events

Key facts about DR. PH. DE VUSSER

What is the company number of DR. PH. DE VUSSER?
The company number of DR. PH. DE VUSSER is 0462.922.008. The VAT number is the same number with BE in front: BE 0462.922.008.
Where is DR. PH. DE VUSSER based?
The registered office is at Hoefstadstraat 93, 3600 Genk.Company details
What is the legal form of DR. PH. DE VUSSER?
The legal form of DR. PH. DE VUSSER is Private limited company (BV).
When was DR. PH. DE VUSSER founded?
DR. PH. DE VUSSER was founded on 20-03-1998.
Is DR. PH. DE VUSSER still active?
Yes, DR. PH. DE VUSSER is an active enterprise in the KBO register.
What is the turnover of DR. PH. DE VUSSER?
The turnover in financial year 2025 is ≈ €2.0m. This figure is estimated from the gross margin of €1.1m and 55 comparable companies of the same size. It probably lies between €1.3m and €2.6m. It is a rough estimate.Financials
Is DR. PH. DE VUSSER profitable?
In financial year 2025, DR. PH. DE VUSSER made a profit of €702,124.
Where can I find the annual accounts of DR. PH. DE VUSSER?
DR. PH. DE VUSSER filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. PH. DE VUSSER due?
DR. PH. DE VUSSER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.